Industry response to the Spanish governmental Plan for the Promotion of R&D within the Pharmaceutical Industry (1986–1996)

Isabel Pérez-Escolano and Gonzalo París

Science and Public Policy, 2004, vol. 31, issue 4, 301-312

Abstract: Spain joining the European Community (European Union (EU), today) in 1986 brought it into a much more competitive environment. The Plan for the Promotion of R&D within the Pharmaceutical Industry (FARMA) was one of the R&D programmes designed by the Government within an important reform plan aiming to facilitate the development of several industrial sectors. Several input-output indicators are reviewed to measure the effort made, the resources provided by the pharmaceutical companies and the outcome of the programme in the 1986–1996 period. Global resources devoted to R&D increased slightly. Domestic companies contributed more than multinationals, thus enabling the former to discover, develop and commercialise some new products in some EU markets and in the USA. Copyright , Beech Tree Publishing.

Date: 2004
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.3152/147154304781779958 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:scippl:v:31:y:2004:i:4:p:301-312

Access Statistics for this article

Science and Public Policy is currently edited by Nicoletta Corrocher, Jeong-Dong Lee, Mireille Matt and Nicholas Vonortas

More articles in Science and Public Policy from Oxford University Press
Bibliographic data for series maintained by Oxford University Press ().